Evidence map›Paper›PMID 11314029›Full record

ArticleOncogene2001

Cellular and viral Fos proteins are degraded by different proteolytic systems.

C Acquaviva, C Salvat, F Brockly, G Bossis, P Ferrara, M Piechaczyk, I Jariel-Encontre

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C AcquavivaInstitut de Génétique Moléculaire/UMR5535 /IFR24, CNRS, 1919, route de Mende, 34293-Montpellier Cedex 05-France.
C Salvat
F Brockly
G Bossis
P Ferrara
M Piechaczyk
I Jariel-Encontre
Centre National de la Recherche Scientifique · FRInstitut de Génétique Moléculaire de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

c-Fos proto-oncoprotein is a short-lived transcription factor degraded by the proteasome in vivo. Its mutated forms expressed by the mouse osteosarcomatogenic retroviruses, FBJ-MSV and FBR-MSV, are stabilized two- and threefold, respectively. To elucidate the mechanisms underlying v-Fos(FBJ) and v-Fos(FBR) protein stabilization, we conducted a genetic analysis in which the half-lives and the sensitivities to various cell-permeable protease inhibitors of a variety of cellular and viral protein mutants were measured. Our data showed that the decreased degradation of v-Fos(FBJ) and v-Fos(FBR) is not simply explained by the deletion of a c-Fos destabilizing C-terminal domain. Rather, it involves a complex balance between opposing destabilizing and stabilizing mutations which are distinct and which include virally-introduced peptide motifs in both cases. The mutations in viral Fos proteins conferred both total insensitivity to proteasomal degradation and sensitivity to another proteolytic system not naturally operating on c-Fos, explaining the limited stabilization of the two proteins. This observation is consistent with the idea that FBR-MSV and FBJ-MSV expression machineries have evolved to ensure controlled protein levels. Importantly, our data illustrate that the degradation of unstable proteins does not necessarily involve the proteasome and provide support to the notion that highly related proteins can be broken down by different proteolytic systems in living cells.

Indexed as

Amino Acid SequenceAnimalsCOS CellsCysteine EndopeptidasesFrameshift MutationHalf-LifeMultienzyme ComplexesMyristic AcidOncogene Proteins v-fosPoint MutationProtease InhibitorsProteasome Endopeptidase ComplexProtein Processing, Post-TranslationalProtein Structure, TertiaryProto-Oncogene Proteins c-fosSarcoma Viruses, MurineCysteine EndopeptidasesMultienzyme ComplexesMyristic AcidOncogene Proteins v-fosProtease InhibitorsProteasome Endopeptidase ComplexProto-Oncogene Proteins c-fos

Identifiers

PMID11314029
OpenAlexW2068244923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.